Home | All trials

[RDF data]
Trial NCT00878566

Resource URI: http://static.linkedct.org/resource/trials/NCT00878566
linkedct:acronym RxAction
linkedct:arm_group <http://static.linkedct.org/resource/arm_group/44701>
linkedct:arm_group <http://static.linkedct.org/resource/arm_group/64233>
linkedct:brief_title Rural Alberta Clinical Trial in Optimizing Hypertension
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/1060>
linkedct:condition <http://static.linkedct.org/resource/condition/6238>
linkedct:criteria Inclusion Criteria: - If overall average (after 2 visits) systolic 180 OR diastolic 110 mmHg in patients without macrovascular target organ damage, diabetes or chronic kidney disease - If overall average (after 2 visits) systolic 140 OR diastolic 90 for patients with undiagnosed hypertension with macrovascular target organ damage (coronary artery disease, cerebrovascular disease, DM), include patient. - In patients with diagnosed hypertension above target blood pressure, systolic 140 ( 130 with DM or CKD) OR diastolic 90, ( 80 with DM or CKD), include patient. Exclusion Criteria: - Patients with hypertensive urgency or emergency: - Urgency: SBP  180 mm Hg or DBP  120 mm Hg with no acute signs of end-organ damage - Unwilling to participate/sign consent form - Pregnancy
linkedct:description The study is a randomized, controlled trial of enhanced pharmacist care, with the unit of randomization as the patient. Participants will be randomized to enhanced pharmacist care (patient identification, assessment, education, close follow-up and prescribing/titration of antihypertensive medications or usual care. Participants will be patients in rural Alberta with undiagnosed or uncontrolled BP as defined by the Canadian Hypertension Education Program. The primary intervention will be enhanced pharmacist care. Pharmacists will assess patients with regards to cardiovascular risk reduction including reviewing BP control, treatment goals and determining lifestyle modifications for the patient to undertake to help manage their BP. The primary outcome will be a comparison of difference in change in systolic BP between enhanced care and usual care at 24 weeks follow-up. Secondary outcomes include the number of patients at their BP target at 24 weeks, number of new antihypertensive medication starts, number of antihypertensive dosage changes, number of antihypertensive medication changes and number of new prescriptions for ASA and cholesterol medications.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers Accepts Healthy Volunteers
linkedct:eligibility_maximum_age N/A
linkedct:eligibility_minimum_age 18 Years
linkedct:end_date August 2010
linkedct:enrollment 340 (xsd:int)
linkedct:firstreceived_date April 8, 2009
linkedct:has_dmc No
linkedct:id NCT00878566
linkedct:intervention <http://static.linkedct.org/resource/intervention/119757>
linkedct:intervention <http://static.linkedct.org/resource/intervention/82096>
rdfs:label Trial NCT00878566
linkedct:lastchanged_date December 3, 2009
linkedct:lead_sponsor_agency University of Alberta
linkedct:location <http://static.linkedct.org/resource/location/22480>
linkedct:nct_id NCT00878566
linkedct:number_of_arms 2 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Rural Alberta Clinical Trial in Optimizing Hypertension: The Rural RxAction Study
linkedct:org_study_id Pro00005300
linkedct:overall_contact_email theresa.charrois@ualberta.ca
linkedct:overall_contact_last_name Theresa L. Charrois, BScPharmMSc
linkedct:overall_contact_phone 780.492.3792
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/52082>
linkedct:overall_status Recruiting
linkedct:oversight <http://static.linkedct.org/resource/oversight/410>
foaf:page <http://clinicaltrials.gov/show/NCT00878566>
linkedct:phase N/A
linkedct:primary_completion_date March 2010
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/38374>
linkedct:secondary_outcomes <http://static.linkedct.org/resource/secondary_outcomes/42324>
linkedct:secondary_outcomes <http://static.linkedct.org/resource/secondary_outcomes/68875>
linkedct:secondary_outcomes <http://static.linkedct.org/resource/secondary_outcomes/68984>
linkedct:secondary_outcomes <http://static.linkedct.org/resource/secondary_outcomes/68996>
linkedct:source University of Alberta
linkedct:start_date November 2009
linkedct:study_design Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to evaluate the effect of enhanced pharmacist care (patient identification, assessment, education, prescribing/titration of antihypertensive medications and close follow-up) on systolic blood pressure (BP) reduction in patients with poorly controlled hypertension in the rural setting.
rdf:type linkedct:trials
linkedct:verification_date December 2009